PMPasquale Martinelli

Pasquale Martinelli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pasquale Martinelli has a total of 94 co-authors. Here are the top co-authors by number of shared publications:

  • Giuseppe Maria Maruotti

    A Department of Neuroscience, Reproductive Sciences and Dentistry , School of Medicine, University of Naples "Federico II" , Naples , Italy

    24 shared publications
  • Laura Sarno

    Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy

    9 shared publications
  • Gabriele Saccone

    Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy

    8 shared publications
  • Raffaele Napolitano

    High Risk Pregnancy Unit Department of Obstetrics and Gynecology University Federico II Naples Italy

    7 shared publications
  • Annalisa Agangi

    Prenatal Diagnosis Unit, Department of Gynecology and Obstetrics, University Federico II, Naples, Italy

    6 shared publications
  • Maddalena Morlando

    Obstetrics and Gynecology Unit, Department of Woman, Child and General and Specialized Surgery University of Campania “Luigi Vanvitelli” Naples Italy

    4 shared publications

Latest Publications

  • Low molecular weight heparin use during pregnancy and risk of postpartum hemorrhage: a systematic review and meta-analysis

    by Angelo Sirico, Gabriele Saccone, Giuseppe Maria Maruotti, Elvira Grandone, Laura Sarno, Vincenzo Berghella, Fulvio Zullo, Pasquale Martinelli

    Introduction: Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide with a prevalence rate of approximately 6%. Although most cases of PPH have no identifiable risk factors, the incidence of PPH has been associated to the thromboprophylaxis in pregnancy with low molecular weight heparin (LMWH). Thus, the aim of the study is to evaluate the risk of PPH in cases of pregnant women exposed to LMWH. Materials and methods: Electronic research was performed in OVID, Scopus, ClinicalTrials.gov, MEDLINE, the PROSPERO International Prospective Register of Systematic Reviews, EMBASE, and the Cochrane Central Register of Controlled Trials through April 2016. We included randomized controlled trials, cohort and case-control studies of women who underwent thromboprophylaxis with LMWH during pregnancy compared to a control group (either placebo or no treatment). The primary outcome was the incidence of PPH. The summary measures were reported as relative risk (RR) or as mean differences (MD) with 95% confidence interval (CI). Results: Eight studies including 22,162 women were analyzed. Of the 22,162 women, 1320 (6%) were administered LMWH, 20,842 (94%) women formed the nonexposed group (control group). Women treated with LMWH had a higher risk of PPH (RR 1.45, 95%CI 1.02–2.05) compared to controls; there was no difference in mean of blood loss at delivery (MD −32.90, 95%CI 68.72–2.93) and in risk of blood transfusion at delivery (RR 1.24, 95%CI 0.62–2.51), respectively. Conclusions: Women who receive LMWH during pregnancy have a significantly higher risk of developing PPH. Women who receive LMWH during pregnancy have neither significantly higher mean blood loss at delivery nor higher risk of blood transfusion.


  • Screening for cervical carcinoma in HIV‐infected women: Analysis of main risk factors for cervical cytologic abnormalities

    by Matilde Sansone, Gabriele Saccone, Annalisa Migliucci, Rosa Saviano, Angela Capone, Giuseppe Maria Maruotti, Dario Bruzzese, Pasquale Martinelli

    Aim: The aim of this study was to identify potential predictive factors for cervical disease in women with HIV and to evaluate adherence during follow‐up to cervical cancer screening.Methods: In order to identify the independent role of factors associated with the presence of a cervical abnormality, all of the variables showing in univariate analyses a potential association with the outcome variable (presence of cervical abnormalities) were entered into a multivariate logistic regression model, along with age at first visit to our center, and age at diagnosis.Results: A total of 540 HIV‐positive women who received screening for cervical cancer during the first year after their first visit to our center were included in the analysis; 423 (78.3%) had normal cytology and 117 (21.7%) had cytological abnormalities, classified as follows: 21 atypical squamous cells of undetermined significance (17.9%); 51 low‐grade squamous intraepithelial lesions (43.6%); 41 high‐grade squamous intraepithelial lesions (35.0%); and four cervical cancers (3.4%). In our study, women with more than two previous pregnancies were significantly associated with a lower risk of cervical cytological abnormalities compared to the other women. Women with CD4+ levels of 200–499/mm3 had a higher risk of developing cervical cytological abnormalities compared to those with a CD4+ level > 500/ mm3.Conclusion: In summary, management of HIV‐positive women must be modeled on HIV‐clinical status, CD4+ cell count, drug regimen, and adherence to follow‐up, relying on the cooperation of highly qualified professionals. In HIV‐positive women, an adequate screening and follow‐up allows for a reduced occurrence of advanced cervical disease and prevents recourse to invalidating surgical interventions.


  • Diagnostic accuracy of intracranial translucency in detecting spina bifida: a systematic review and meta-analysis

    by Giuseppe M. Maruotti, Gabriele Saccone, Francesco D'Antonio, Vincenzo Berghella, Laura Sarno, Maddalena Morlando, Antonia Giudicepietro, Pasquale Martinelli

    To evaluate the diagnostic accuracy of intracranial translucency(IT) in the detection of spina bifida in the first trimester of pregnancy We included study assessing the accuracy of sonographic measurements of IT in a mid-sagittal view of the fetal face in prediction of spina bifida in the first trimester of pregnancy. The primary outcome was the accuracy of IT in prediction of spina bifida. Summary estimates of sensitivity, specificity, positive and negative likelihood ratios (LR + andLR–) and diagnostic odds ratio (DOR) for the overall predictive accuracy of IT were computed. 9studies(21,070fetuses)were included in the analysis. IT was successfully assessed in the majority of fetuses 97.8% (95%CI 97.6-98.0). The diagnostic performance of IT in detecting spina bifida was as follows: sensitivity:53.5% (95%CI42.4-64.3); specificity:99.7% (95%CI99.6-99.8); LR+:62.1 (95%CI12.2-317); LR-:0.55 (95%CI0.45-0.68); DOR: 223 (95%CI25-2039). IT had low diagnostic accuracy in prediction of open spina bifida thus questioning its role as a screening marker for OSB in an unselected population. When looking at the individual study data, it appears that IT assessment for OSB prediction can be affected by a high rate of false positive results potentially leading to unnecessary parental anxiety.


  • Third trimester ultrasound soft-tissue measurements accurately predicts macrosomia

    by Giuseppe Maria Maruotti, Gabriele Saccone, Pasquale Martinelli

    Objective: To evaluate the accuracy of sonographic measurements of fetal soft tissue in the prediction of macrosomia. Methods: Electronic databases were searched from their inception until September 2015 with no limit for language. We included only studies assessing the accuracy of sonographic measurements of fetal soft tissue in the abdomen or thigh in the prediction of macrosomia ≥34 weeks of gestation. The primary outcome was the accuracy of sonographic measurements of fetal soft tissue in the prediction of macrosomia. We generated the forest plot for the pooled sensitivity and specificity with 95% confidence interval (CI). Additionally, summary receiver-operating characteristics (ROC) curves were plotted and the area under the curve (AUC) was also computed to evaluate the overall performance of the diagnostic test accuracy. Results: Three studies, including 287 singleton gestations, were analyzed. The pooled sensitivity of sonographic measurements of abdominal or thigh fetal soft tissue in the prediction of macrosomia was 80% (95% CI: 66–89%) and the pooled specificity was 95% (95% CI: 91–97%). The AUC for diagnostic accuracy of sonographic measurements of fetal soft tissue in the prediction of macrosomia was 0.92 and suggested high diagnostic accuracy. Conclusions: Third-trimester sonographic measurements of fetal soft tissue after 34 weeks may help to detect macrosomia with a high degree of accuracy. The pooled detection rate was 80%. A standardization of measurements criteria, reproducibility, building reference charts of fetal subcutaneous tissue and large studies to assess the optimal cutoff of fetal adipose thickness are necessary before the introduction of fetal soft-tissue markers in the clinical practice.


  • Celiac disease and obstetric complications: a systematic review and metaanalysis

    by Gabriele Saccone, Vincenzo Berghella, Laura Sarno, Giuseppe M. Maruotti, Irene Cetin, Luigi Greco, Ali S. Khashan, Fergus McCarthy, Domenico Martinelli, Francesca Fortunato, et al.


  • Maternal body mass index influences umbilical artery Doppler velocimetry in physiologic pregnancies

    by Laura Sarno, Giuseppe Maria Maruotti, Gabriele Saccone, Maddalena Morlando, Angelo Sirico, Pasquale Martinelli

    Objectives: The aim of our study was to assess whether there is a relationship between maternal body mass index (BMI) and umbilical artery Doppler velocimetry in physiologic pregnancies.Methods: Healthy pregnancy women, referred to our center at or before 32 weeks of gestation, were recruited. According to BMI, they were divided into underweight (BMI < 18.5), normal weight (BMI 18.5–24.9), overweight (BMI 25.0–29.9) and obese women (BMI ≥ 30). At 32+0 weeks of gestation, maternal BMI and umbilical artery Doppler velocimetry were recorded. A correlation between pulsatility index of umbilical artery and BMI was assessed by one‐way ANOVA test, multiple comparison test (Bonferroni correction) and polynomial regression.Results: One hundred eighty‐five women were included. Mean pulsatility index of umbilical artery at 32+0 was significantly higher in obese women (0.95 ± 0.01 vs 0.87 ± 0.01 vs 0.67 ± 0.01; p < 0.05). We found a positive correlation between Pulsatility Index of Umbilical Artery and maternal BMI (r2 = 0.7; p < 0.05).Conclusion: There is a positive correlation between BMI and pulsatility index of umbilical artery. These findings suggest that obesity has a negative effect on feto‐placetal vessels. If our data will be confirmed, maternal BMI should be considered in evaluation of umbilical Doppler velocimetry. © 2014 John Wiley & Sons, Ltd.


  • Risk of preeclampsia: comparison between dichorionic and monochorionic twin pregnancies

    by Laura Sarno, Giuseppe Maria Maruotti, Vera Donadono, Gabriele Saccone, Pasquale Martinelli


  • Prenatal screening and counseling for genetic disorders

    by Giuseppe Maria Maruotti, Laura Sarno, Stefania Simioli, Giuseppe Castaldo, Pasquale Martinelli

    Introduction: The carriers of the same autosomal recessive disorder are usually unaware of onset of the genetic diseases in the children even if screenings are available for many of these disorders. In this paper, we report the experience of the Prenatal Diagnosis Center of AOU Federico II and we discuss the role of the screening for beta-thalassemia (BT), cystic fibrosis (CF) and for other rare genetic disorders. Materials and Methods: We analyzed retrospectively the indication for Prenatal Diagnosis (PD) of all the couples referred to our center from January 1993 to May 2013. We divided our sample into three groups: couples at high risk for BT, for CF and for other rare genetic disorders. Results: From January 1993 to May 2013, we performed 1269 PD for genetic disorders. There are still couples who discovered to be carriers of BT by screening after the birth of the affected child (n = 51 (11,3%)); the majority of the people were screened for CF carrier after the birth of an affected child (n = 155 (80,7%)) or through the cascade screening (n = 28 (14,6%)). Large-scale screenings for rare genetic conditions are not available and people were screened only if they have a positive familial history. Conclusion: Parental screening is available for many severe and rare diseases whose genetic origin is known. The proportion of patients referred for very high-risk indications increased over time with an higher demand for rare disease. An adequate counseling is fundamental to identify women at risk for having affected child. Screening, counseling and PD of genetic diseases is a complex matter and needs for a continuous update.